Q1 2025 · 13F-HR
Madison Avenue Partners, LPholdings as filed
Filed 2025-05-15 · accession 0001801265-25-000004
$1.18B
Reported value
22
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 384637104 | GHC | GRAHAM HLDGS CO | $235.7M | 20.0% | 245,271 | Common | SOLE |
| 83444M101 | SOLV | SOLVENTUM CORP | $213.9M | 18.2% | 2,813,017 | Common | SOLE |
| 570535104 | MKL | MARKEL GROUP INC | $170.8M | 14.5% | 91,357 | Common | SOLE |
| 968223206 | WLY | WILEY JOHN & SONS INC | $98.4M | 8.35% | 2,208,066 | Common | SOLE |
| G8807B106 | TBPH | THERAVANCE BIOPHARMA INC | $84.9M | 7.21% | 9,511,150 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $74.3M | 6.30% | 7,792,089 | Common | SOLE |
| 55939A107 | MAGN | MAGNERA CORP | $60.7M | 5.16% | 3,344,005 | Common | SOLE |
| 69331C108 | PCG | PG&E CORP | $50.7M | 4.30% | 2,950,000 | Common | SOLE |
| 457651107 | INVX | INNOVEX INTERNATIONAL INC | $43.3M | 3.68% | 2,413,608 | Common | SOLE |
| 85256A109 | STGW | STAGWELL INC | $43.2M | 3.67% | 7,147,662 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $35.6M | 3.02% | 4,477,798 | Common | SOLE |
| 64031N108 | NNI | NELNET INC | $25.9M | 2.20% | 233,830 | Common | SOLE |
| 199333105 | CMCO | COLUMBUS MCKINNON CORP N Y | $10.5M | 0.89% | 619,343 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $10.2M | 0.87% | 4,142,640 | Common | SOLE |
| 13765N107 | CNNE | CANNAE HLDGS INC | $7.7M | 0.65% | 418,984 | Common | SOLE |
| 35471R106 | FSP | FRANKLIN STR PPTYS CORP | $4.9M | 0.41% | 2,733,418 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $2.9M | 0.24% | 579,895 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $2.3M | 0.19% | 1,675,043 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $769,028 | 0.07% | 2,465,623 | Common | SOLE |
| G8068L108 | SN | SHARKNINJA INC | $513,138 | 0.04% | 6,152 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $410,874 | 0.03% | 100,952 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY INC | $287,616 | 0.02% | 9,486 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.